Applied Therapeutics, Inc. announced the appointment of Adam Hansard as Chief Commercial Officer. Mr. Hansard brings extensive experience across the biotech and pharmaceutical industry to Applied Therapeutics, ranging from rare disease to large commercial indications. Prior to joining Applied Therapeutics, Mr. Hansard was Senior Director of New Product Strategy at Alexion Pharmaceuticals, where he led a company-wide business unit team, ran the ALXN1830 commercial team, and was responsible for commercial evaluation of strategic business development opportunities.